-
EASE OF USE OF TIRZEPATIDE: RESULTS FROM A US SURVEY OF INDIVIDUALS WITH OBESITY OR OVERWEIGHT
Mar 18, 2026, 21:38 PM -
AUTOMATED PERITONEAL DIALYSIS (APD) VS HEMODIALYSIS (HD) IN CHINA: COST-UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF TRIFLURIDINE/TIPIRACIL PLUS BEVACIZUMAB VERSUS REGORAFENIB IN REFRACTORY METASTATIC COLORECTAL CANCER IN KAZAKHSTAN
Mar 18, 2026, 21:38 PM -
ENHANCING REAL-WORLD DATA COMPLETENESS IN TYPE 2 DIABETES THROUGH LINKAGE OF CLAIMS, EMR, AND LABORATORY DATA
Mar 18, 2026, 21:38 PM -
ESTIMATING MEANINGFUL CHANGE THRESHOLDS (MCTS) FOR EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC) SCALES IN A PHASE 3 TRIAL FOR PATIENTS WITH LOCALLY RECURRENT INOPERABLE OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)
Mar 18, 2026, 21:38 PM -
EVALUATING AI MODELS FOR DRUG PRICING ANALYTICS: A COMPARATIVE STUDY FOR MOST-FAVORED-NATION POLICY MODELING
Mar 18, 2026, 21:38 PM -
DOES SUBSTANDARD CANCER CARE ADVERSELY IMPACT PATIENT FINANCIAL WELL BEING? AN ANALYSIS OF CANCER REGISTRY, CLAIMS, AND CREDIT REPORT SCORES
Mar 18, 2026, 21:38 PM -
STRUCTURED EXPERT ELICITATION IN GLOBAL HTAS: ACCEPTANCE AND APPLICATION
Mar 18, 2026, 21:38 PM -
PREDICTING OVERALL SURVIVAL FROM SURROGATE ENDPOINTS: A TWO-STAGE BAYESIAN META-ANALYTIC SURROGACY FRAMEWORK INCORPORATING RECOVERED INDIVIDUAL-LEVEL DEPENDENCE INFORMATION
Mar 18, 2026, 21:38 PM -
USER EVALUATION OF AN AGENTIC AI ASSISTANT FOR REAL-WORLD EVIDENCE FEASIBILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-MINIMIZATION ANALYSIS OF OCTOCOG ALFA VERSUS EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS IN CENTRAL AMERICA, ECUADOR AND PERÚ
Mar 18, 2026, 21:38 PM -
REAL-WORLD EPIDEMIOLOGY, CLINICAL OUTCOMES AND PATIENT SATISFACTION AMONG USERS OF ARTIFICIAL PANCREAS SYSTEMS IN TYPE 1 AND TYPE 2 DIABETES INSIGHTS FROM PHYSICIAN NOTES USING NLP
Mar 18, 2026, 21:38 PM -
EVOLUTION OF PATIENT-REPORTED BURDEN AND UNMET NEEDS IN HEREDITARY ANGIOEDEMA: A COMPARATIVE SOCIAL MEDIA LISTENING ANALYSIS
Mar 18, 2026, 21:38 PM -
PREVALENCE OF DEPRESSION AMONG ADULTS WITH SICKLE CELL DISEASE IN TEXAS MEDICAID
Mar 18, 2026, 21:38 PM -
SOCIAL DETERMINANTS OF HEALTH AND GLP-1 PRESCRIBING PATTERNS IN T2D AND OBESITY: REAL-WORLD EVIDENCE FROM A LARGE, NATIONAL U.S. LINKED EHR-CLAIMS NETWORK
Mar 18, 2026, 21:38 PM -
REAL-WORLD BUDGET IMPACT ANALYSIS OF BIOSIMILAR ADOPTION IN A MEDIUM-SIZED BRAZILIAN HEALTH MAINTENANCE ORGANIZATION (HMO)
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH OVERDOSE RISK AMONG PERINATAL WOMEN WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
WHEN NOT TO USE ARTIFICIAL INTELLIGENCE IN HEALTH ECONOMICS AND OUTCOMES RESEARCH
Mar 18, 2026, 21:38 PM -
IMPACT OF METHOD CHOSEN FOR DEFINING OBSERVABLE TIME IN LINKED OPEN DATA SOURCES
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS AND HARMS OF SUSTAINED STATIN THERAPY AMONG YOUNG ADULTS
Mar 18, 2026, 21:38 PM
